ATA91479A - Verfahren zur herstellung neuer ergolinderivate - Google Patents

Verfahren zur herstellung neuer ergolinderivate

Info

Publication number
ATA91479A
ATA91479A AT0091479A AT91479A ATA91479A AT A91479 A ATA91479 A AT A91479A AT 0091479 A AT0091479 A AT 0091479A AT 91479 A AT91479 A AT 91479A AT A91479 A ATA91479 A AT A91479A
Authority
AT
Austria
Prior art keywords
producing new
derivatives
ergol derivatives
new ergol
producing
Prior art date
Application number
AT0091479A
Other languages
English (en)
Other versions
AT371817B (de
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to AT554281A priority Critical patent/AT385988B/de
Priority to AT554181A priority patent/AT385987B/de
Publication of ATA91479A publication Critical patent/ATA91479A/de
Application granted granted Critical
Publication of AT371817B publication Critical patent/AT371817B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0091479A 1978-02-08 1979-02-07 Verfahren zur herstellung neuer ergolinderivate AT371817B (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT554281A AT385988B (de) 1978-02-08 1981-12-23 Verfahren zur herstellung neuer ergolinderivate und ihrer salze
AT554181A AT385987B (de) 1978-02-08 1981-12-23 Verfahren zur herstellung neuer ergolinderivate und ihrer salze

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/875,978 US4166182A (en) 1978-02-08 1978-02-08 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds

Publications (2)

Publication Number Publication Date
ATA91479A true ATA91479A (de) 1982-12-15
AT371817B AT371817B (de) 1983-08-10

Family

ID=25366703

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0091479A AT371817B (de) 1978-02-08 1979-02-07 Verfahren zur herstellung neuer ergolinderivate

Country Status (36)

Country Link
US (1) US4166182A (de)
EP (1) EP0003667B1 (de)
JP (1) JPS54115400A (de)
AR (1) AR228341A1 (de)
AT (1) AT371817B (de)
AU (1) AU523172B2 (de)
BE (1) BE873883A (de)
BG (1) BG30474A3 (de)
CA (1) CA1114368A (de)
CH (1) CH639088A5 (de)
CS (1) CS203951B2 (de)
DD (1) DD141928A5 (de)
DE (2) DE2963320D1 (de)
DK (1) DK147362C (de)
EG (1) EG14076A (de)
ES (1) ES477547A1 (de)
FI (1) FI65777C (de)
FR (1) FR2416891A1 (de)
GB (1) GB2014140B (de)
GR (1) GR72776B (de)
HU (1) HU179970B (de)
IE (1) IE47827B1 (de)
IL (1) IL56581A (de)
LU (2) LU80886A1 (de)
MX (2) MX5995E (de)
MY (1) MY8500597A (de)
NL (1) NL930106I2 (de)
NZ (1) NZ189561A (de)
PH (1) PH14903A (de)
PL (3) PL120849B1 (de)
PT (1) PT69172B (de)
RO (3) RO81856A (de)
SU (1) SU912045A3 (de)
UA (1) UA6082A1 (de)
YU (1) YU28279A (de)
ZA (1) ZA79453B (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4246265A (en) * 1979-10-01 1981-01-20 Eli Lilly And Company 6-n-Propyl-8α-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity
CH649998A5 (de) * 1982-08-09 1985-06-28 Sandoz Ag Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.
US4563461A (en) * 1983-03-10 1986-01-07 Eli Lilly And Company Selective method for blocking 5HT2 receptors
US4551529A (en) * 1983-10-06 1985-11-05 Warner-Lambert Company Guanine-N7 -oxide
DE3340025C2 (de) * 1983-11-03 1986-01-09 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 2-Brom-8-ergolinyl-Verbindungen
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
GB2173189B (en) * 1985-02-21 1988-04-27 Maruko Pharmaceutical Co Ergoline derivatives and salts thereof and pharmaceutical compositions thereof
US4683313A (en) * 1985-06-24 1987-07-28 Eli Lilly And Company 2-alkyl(or phenyl)thio-6-N alkyl ergolines and 4-dialkylaminotetrahydrobenz[c,d]indoles
US4782152A (en) * 1985-08-16 1988-11-01 Eli Lilly And Company Decyanation of pergolide intermediate
US4772709A (en) * 1985-10-01 1988-09-20 Eli Lilly And Company Process of making ketoalkanol esters of dihydrolysergic acid
HU196394B (en) * 1986-06-27 1988-11-28 Richter Gedeon Vegyeszet Process for preparing 2-halogenated ergoline derivatives
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
US4797405A (en) * 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
DE3868866D1 (de) * 1987-11-20 1992-04-09 Erba Carlo Spa Ergolinderivate mit antiparkinsonwirkung.
DE3913756A1 (de) * 1989-04-21 1990-10-25 Schering Ag 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung
US5114948A (en) * 1989-10-19 1992-05-19 Eli Lilly And Company Stabilized pergolide compositions
DE3938701A1 (de) * 1989-11-20 1991-05-23 Schering Ag Neue agroclavin- und elymoclavin-derivate, verfahren zu deren herstellung und deren verwendung in arzneimitteln
US5063234A (en) * 1990-05-25 1991-11-05 Eli Lilly And Company Method of inhibiting demineralization of bone
US5272141A (en) * 1990-09-28 1993-12-21 Franco Fraschini Contraceptive and menstrual cycle controlling drug having oncostatic therapeutic properties for treatment of mammary tumors and melanomas, and method therefor
US5416090A (en) * 1991-01-31 1995-05-16 Eli Lilly And Company Method of treating inflammation
US5463060A (en) * 1992-05-21 1995-10-31 Eli Lilly And Company One-pot process
US6572879B1 (en) 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
US6623752B1 (en) 1996-07-02 2003-09-23 Hexal Ag Patch for transdermal application for pergolid
DE19626621A1 (de) * 1996-07-02 1998-01-08 Hexal Ag Pflaster zur transdermalen Anwendung von Pergolid
IT1307934B1 (it) * 1999-01-27 2001-11-29 Poli Ind Chimica Spa Processo per la preparazione di derivati alchimercaptometilergolinici.
AU2635599A (en) * 1999-03-17 2000-10-04 Eugen Eigenmann Use of prolactin inhibitors for the treatment of fertility problems in animal species
US6548484B1 (en) 2000-04-12 2003-04-15 International Medical Innovations, Inc. Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
US6388079B1 (en) 2000-08-29 2002-05-14 Scinopharm Singapore Pte Ltd. Process for preparing pergolide
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
ES2325880T3 (es) 2001-06-08 2009-09-23 Ipsen Pharma Analogos quimericos de somatostatina-dopamina.
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
WO2003078432A2 (en) * 2002-03-15 2003-09-25 Antibioticos S.P.A. Process for the synthesis of pergolide
GB0409785D0 (en) 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline
GB0505965D0 (en) 2005-03-23 2005-04-27 Resolution Chemicals Ltd Preparation of cabergoline
US7339060B2 (en) 2005-03-23 2008-03-04 Resolution Chemicals, Ltd. Preparation of cabergoline
US7939665B2 (en) * 2007-05-04 2011-05-10 Apotex Pharmachem Inc. Efficient process for the preparation of cabergoline and its intermediates
EP2113504A1 (de) * 2008-04-29 2009-11-04 LEK Pharmaceuticals D.D. Zubereitung von N-6-demethylierten 9,10-Dihydrolysergsäure Alkylestern
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途
TWI523863B (zh) 2012-11-01 2016-03-01 艾普森藥品公司 體抑素－多巴胺嵌合體類似物
CN104768565B (zh) 2012-11-01 2017-04-26 益普生制药股份有限公司 促生长素抑制素类似物及其二聚体
JP6242811B2 (ja) 2012-12-10 2017-12-06 キッセイ薬品工業株式会社 新規なオクタヒドロピリドキナゾリン誘導体、それを含有する医薬組成物およびそれらの用途
CN106866656A (zh) * 2017-02-28 2017-06-20 西南交通大学 一类麦角碱衍生物及其在预防和治疗精神疾病的用途
US20190374534A1 (en) 2018-06-08 2019-12-12 Boehringer Ingelheim Vetmedica Gmbh Liquid pharmaceutical compositions comprising pergolide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR206772A1 (es) * 1972-07-21 1976-08-23 Lilly Co Eli Procedimiento para preparar una nueva d-2-halo-6-metil-8-ciano(carboxamido)metil ergolina
US3920664A (en) * 1972-07-21 1975-11-18 Lilly Co Eli D-2-halo-6-alkyl-8-substituted ergolines and related compounds
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3985752A (en) * 1974-12-06 1976-10-12 Eli Lilly And Company 6-Methyl-8-(substituted) methylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4054660A (en) * 1975-04-14 1977-10-18 Eli Lilly And Company Method of inhibiting prolactin
JPS5283894A (en) * 1976-01-01 1977-07-13 Lilly Co Eli 88thiomethyl ergoline

Also Published As

Publication number Publication date
RO81856B (ro) 1983-05-30
JPS54115400A (en) 1979-09-07
NL930106I2 (nl) 1997-02-03
GR72776B (de) 1983-12-05
RO81856A (ro) 1983-06-01
DE2963320D1 (en) 1982-09-02
PL120849B1 (en) 1982-03-31
CA1114368A (en) 1981-12-15
RO81857A (ro) 1983-06-01
UA6082A1 (uk) 1994-12-29
NL930106I1 (nl) 1993-10-18
CH639088A5 (fr) 1983-10-31
CS203951B2 (en) 1981-03-31
NZ189561A (en) 1981-12-15
GB2014140B (en) 1982-08-04
YU28279A (en) 1983-02-28
PL126313B1 (en) 1983-07-30
AU523172B2 (en) 1982-07-15
DK147362C (da) 1988-06-27
MY8500597A (en) 1985-12-31
DE19375112I2 (de) 2003-06-12
AT371817B (de) 1983-08-10
IL56581A (en) 1982-05-31
HU179970B (en) 1983-01-28
DK147362B (da) 1984-07-02
EG14076A (en) 1983-12-31
LU88294I2 (fr) 1994-05-04
PL213283A1 (de) 1980-02-25
EP0003667B1 (de) 1982-07-14
AU4391779A (en) 1979-08-16
US4166182A (en) 1979-08-28
IE790232L (en) 1979-08-08
LU80886A1 (fr) 1979-06-07
FI790351A (fi) 1979-08-09
PH14903A (en) 1982-01-29
ES477547A1 (es) 1980-04-16
IE47827B1 (en) 1984-06-27
EP0003667A1 (de) 1979-08-22
FI65777C (fi) 1984-07-10
AR228341A1 (es) 1983-02-28
DD141928A5 (de) 1980-05-28
FR2416891B1 (de) 1981-10-16
MX9203107A (es) 1992-07-31
BE873883A (fr) 1979-08-02
FR2416891A1 (fr) 1979-09-07
PL124704B1 (en) 1983-02-28
DK51379A (da) 1979-09-18
BG30474A3 (en) 1981-06-15
RO81857B (ro) 1983-05-30
PT69172B (pt) 1992-05-29
SU912045A3 (ru) 1982-03-07
PT69172A (en) 1979-03-01
ZA79453B (en) 1980-09-24
JPS6363544B2 (de) 1988-12-07
IL56581A0 (en) 1979-05-31
FI65777B (fi) 1984-03-30
GB2014140A (en) 1979-08-22
RO76889A (ro) 1981-08-30
MX5995E (es) 1984-09-18

Similar Documents

Publication Publication Date Title
AT371817B (de) Verfahren zur herstellung neuer ergolinderivate
AT372094B (de) Verfahren zur herstellung neuer corticoid-21halogen-17-alkylcarbonate
AT373599B (de) Verfahren zur herstellung neuer rifamycinderivate
AT362364B (de) Verfahren zur herstellung neuer phenylimi- dazolidinonderivate
AT372086B (de) Verfahren zur herstellung neuer propanonderivate
AT368755B (de) Verfahren zur herstellung neuer alkyl-ketohexopyranosidderivate
AT373251B (de) Verfahren zur herstellung neuer d-6-n-propylergoline
ATA246780A (de) Verfahren zur herstellung neuer pyrazinobenzodiazepine
AT367403B (de) Verfahren zur herstellung neuer chinolin-2onderivate
AT358601B (de) Verfahren zur herstellung neuer nitrosoharn- stoff-derivate
PT71116A (de) Verfahren zur herstellung neuer cyclobutandicarbonsaureimide
AT362389B (de) Verfahren zur herstellung neuer nitrosoharn- stoff-derivate
ATA90478A (de) Verfahren zur herstellung neuer everninomicin- derivate
AT356294B (de) Verfahren zur herstellung neuer ergolinderivate
AT376217B (de) Verfahren zur herstellung neuer 3-chlorchinolinderivate
AT380014B (de) Verfahren zur herstellung neuer oxazolidin-2-on- derivate
AT362798B (de) Verfahren zur herstellung neuer nitrosoharnstoff-derivate
PT67639A (de) Verfahren zur herstellung neuer indolylglyoxylsaeurederivate
AT370085B (de) Verfahren zur herstellung neuer aminobenzoesaeure- derivaten
ATA229781A (de) Verfahren zur herstellung neuer glucosederivate
ATA229981A (de) Verfahren zur herstellung neuer glucosederivate
ATA229881A (de) Verfahren zur herstellung neuer glucosederivate
AT376658B (de) Verfahren zur herstellung neuer carboxyphenyloder -toluylsulfoniumsalze
AT373240B (de) Verfahren zur herstellung neuer pyridyloxyphenoxyalkancarbonsaeurederivate
ATA153980A (de) Verfahren zur herstellung neuer 3-oxaloamino-4- oxo-4h-1-benzopyranderivate

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee
SZA Application filed for a certificate of protection

Free format text: SZ77/94, 941213

SZA Application filed for a certificate of protection

Free format text: SZ 77/94, 941213

ELA Expired due to lapse of time